Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi
Wadhwa et al., medRxiv, doi:10.1101/2022.07.01.22277163
https://c19early.org/wadhwa.html